top of page
ECTRIMS Pre-Day 2024
This exploratory day ahead of the annual ECTRIMS meeting targeted specialised topics in multiple sclerosis and related neuroinflammatory autoimmune diseases.
ECTRIMS Pre-Day aims to catalyse collaboration, forge connections, and provide the support each specialised group deserves.
_QWB2628.jpg

Sessions

Presentations on Paediatric MS, NMOSD/MOGAD and Encephalitis

Chairpersons:

  • Josep Dalmau (Barcelona, ES)

  • Brenda Banwell (Philadelphia, US)

  • Jacqueline Palace (Oxford, UK)

Speakers:

  • Giulia Fadda (Ottawa, CA)

  • Soumya Yandamuri (Yale, US)

  • Frank Leypoldt (Kiel, DE)

  • Romana Höftberger (Vienna, AT)

Antibodies assays: measuring and pathogenesis. 

Chairpersons:

  • Sara Mariotto (Verona, IT)

  • Sean Pittock (Rochester, US)

  • Romain Marignier (Lyon, FR)

Speakers:

  • Marianna Spatola (Barcelona, ES)

  • Patrick Waters (Oxford, UK)

Cognitive consequences of pediatric MS, the challenges of diagnosing seronegative autoimmune encephalitis, innovative treatments in NMOSD/MOGAD, and the neurological complications of immune checkpoint inhibitors.

Chairpersons:

  • Michael Yeaman (UCLA, US)

  • Thaïs Armangué (Barcelona, ES)

  • Bruno Stankoff (Paris, FR)

Speakers:

  • Maria Pia Amato (Florence, IT)

  • Maarten Titulaer (Rotterdam, NL)

  • Scott Zamvil (UCSF, US)

  • Jerome Honorat (Lyon, FR)

Novel trial design in rare diseases (Clinical session)

Chairpersons:

  • Maria Pia Sormani (Genoa, IT)

  • Friedemann Paul (Berlin, DE)

  • Maarten Titulaer (Rotterdam, NL)

Speakers:

  • Ruth Geraldes (Oxford, UK)

  • Barbara Kornek (Vienna, AT)

ABOUT US 

MEDEN is a European group of clinicians and scientists focused on neuromyelitis optica spectrum disorders and myelin oligodendrocyte antibody associated disorder.

We meet annually to discuss projects, controversial topics and set priorities for future work.

© 2025 by Quirin Bellmann.

bottom of page